Latest current cash for MTACW: $57M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), MTACW shows a current cash of $57M. That compares with $13M in the prior-year period — up 335.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MTACW's current cash is now $57M (was $13M) — a 335.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MedTech Acquisition - Warrants (18/12/2025) is outperforming or lagging.
Tracking MTACW's current cash over time shows whether MedTech Acquisition - Warrants (18/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $57M That compares with $13M in the prior-year period — up 335.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has MedTech Acquisition - Warrants (18/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $57M) with ownership activity and broader fundamentals.